New insights into the human 5-HT₄ receptor binding site: exploration of a hydrophobic pocketRIVAIL, Lucie; GINER, Mireille; GASTINEAU, Monique et al.British journal of pharmacology. 2004, Vol 143, Num 3, pp 361-370, issn 0007-1188, 10 p.Article

Review article: tegaserod: the global experienceCHEY, W. D.Alimentary pharmacology & therapeutics. Supplement. 2004, Vol 20, Num 7, pp 15-19, issn 0953-0673, 5 p.Article

Assignment^a of 5-hydroxytryptamine receptor (htr4) to human chromosome 5 bands q31 → q33 by in situ hybridizationCLAEYSEN, S; FAYE, P; SEBBEN, M et al.Cytogenetics and cell genetics. 1997, Vol 78, Num 2, pp 133-134, issn 0301-0171Article

Anomalies de la prise alimentaire chez la souris dépourvue de récepteur 5-HT₄ : Implications physiologiques et physiopathologiques de la sérotonine : nouvelles données chez les souris K0 = Feeding disorders in 5-HT₄ receptor knockout mice : Physiological and physiopathological roles of serotonin: recent data from K0 miceCOMPAN, Valérie; CHARNAY, Yves; DUSTICIER, Nicole et al.Journal de la Société de biologie. 2004, Vol 198, Num 1, pp 37-49, issn 1295-0661, 13 p.Article

Cloning and expression of a human serotonin 5-HT₄ receptor cDNAVAN DEN WYNGAERT, I; GOMMEREN, W; VERHASSELT, P et al.Journal of neurochemistry. 1997, Vol 69, Num 5, pp 1810-1819, issn 0022-3042Article

[³H]5-hydroxytryptamine labels the agonist high affinity state of the cloned rat 5-HT₄ receptorADHAM, N; GERALD, C; SCHECHTER, L et al.European journal of pharmacology. 1996, Vol 304, Num 1-3, pp 231-236, issn 0014-2999, 5 p.Article

Metabolism and Pharmacokinetics of Naronapride (ATI-7505), a Serotonin 5-HT₄ Receptor Agonist for Gastrointestinal Motility DisordersBOWERSOX, S. Scott; LIGHTNING, Luke K; RAO, Satish et al.Drug metabolism and disposition. 2011, Vol 39, Num 7, pp 1170-1180, issn 0090-9556, 11 p.Article

Tegaserod Treatment for Dysmotility-Like Functional Dyspepsia : Results of two Randomized Controlled TrialsVAKIL, Nimish; LAINE, Loren; TALLEY, Nicholas J et al.The American journal of gastroenterology. 2008, Vol 103, Num 8, pp 1906-1919, issn 0002-9270, 14 p.Article

Electrophysiological Characterization of Isolated Human Atrial Myocytes Exposed to TegaserodSUFFREDINI, Silvia; CERBAI, Elisabetta; GIUNTI, Gabriele et al.Basic & clinical pharmacology & toxicology (Print). 2010, Vol 106, Num 5, pp 416-421, issn 1742-7835, 6 p.Article

Tegaserod for constipation-predominant irritable bowel syndromeKALE-PRADHAN, Pramodini B; WILHELM, Sheila M.Pharmacotherapy. 2007, Vol 27, Num 2, pp 267-277, issn 0277-0008, 11 p.Article

Modulation of intestinal gas dynamics in healthy human volunteers by the 5-HT₄ receptor agonist tegaserodCOLESKI, Radoslav; OWYANG, Chung; HASLER, William L et al.The American journal of gastroenterology. 2006, Vol 101, Num 8, pp 1858-1865, issn 0002-9270, 8 p.Article

Perspectives physiopathologiques et thérapeutiques des nouveaux récepteurs sérotoninergiques : à propos du récepteur de type 4 = Pathophysiology and therapeutic applications of serotonin 5-HT4 receptor subtypeLEFEBVRE, H.La Revue de médecine interne (Paris). 2000, Vol 21, Num 8, pp 661-663, issn 0248-8663Article

Rapid Anxiolytic Effects of a 5-HT₄ Receptor Agonist Are Mediated by a Neurogenesis-Independent MechanismMENDEZ-DAVID, Indira; DAVID, Denis J; DARCET, Flavie et al.Neuropsychopharmacology (New York, NY). 2014, Vol 39, Num 6, pp 1366-1378, issn 0893-133X, 13 p.Article

Effects of the 5-HT₄ receptor agonist RS67333 and paroxetine on hippocampal extracellular 5-HT levelsLICHT, Cecilie Löe; KNUDSEN, Gitte Moos; SHARP, Trevor et al.Neuroscience letters. 2010, Vol 476, Num 2, pp 58-61, issn 0304-3940, 4 p.Article

Conformational state of human cardiac 5-HT_4(g) receptors influences the functional effects of polyclonal anti-5-HT₄ receptor antibodiesDI SCALA, Emmanuella; ROSE, Stéphanie; HERAULT, Olivier et al.Biochemical pharmacology. 2007, Vol 73, Num 7, pp 964-971, issn 0006-2952, 8 p.Article

The use of tegaserod in critically ill patients with impaired gastric motilityBANH, Hoan Linh; MACLEAN, Charles; TOPP, Trevor et al.Clinical pharmacology and therapeutics. 2005, Vol 77, Num 6, pp 583-586, issn 0009-9236, 4 p.Article

Systematic review: incidence of abdominal/pelvic surgery amongst patients using tegaserod in randomized controlled trialsSCHOENFELD, P.Alimentary pharmacology & therapeutics. 2004, Vol 19, Num 3, pp 263-269, issn 0269-2813, 7 p.Article

Review article: the safety profile of tegaserodSCHOENFELD, P.Alimentary pharmacology & therapeutics. Supplement. 2004, Vol 20, Num 7, pp 25-30, issn 0953-0673, 6 p.Article

Characterization of the 5-HT₄ binding site in human brainARRANZ, B; ROSEL, P; SAN, L et al.Journal of neural transmission. 1998, Vol 105, Num 6-7, pp 575-586, issn 0300-9564Article

Increased defaecation caused by 5-HT₄ receptor activation in the mouseBANNER, S. E; SMITH, M. I; BYWATER, D et al.European journal of pharmacology. 1996, Vol 308, Num 2, pp 181-186, issn 0014-2999Article

Regional distribution and ontogeny of 5-HT₄ binding sites in rat brainWAEBER, C; SEBBEN, M; BOCKAERT, J et al.Behavioural brain research. 1995, Vol 73, Num 1-2, pp 259-262, issn 0166-4328Conference Paper

The role of the 5-HT₄ receptor in Cl^- secretion in human jejunal mucosaBUDHOO, M. R; HARRIS, R. P; KELLUM, J. M et al.European journal of pharmacology. 1996, Vol 314, Num 1-2, pp 109-114, issn 0014-2999Article

Pharmacological profile of engineered 5-HT₄ receptors and identification of 5-HT₄ receptor-biased ligandsGAVEN, Florence; PELLISSIER, Lucie P; QUEFFEULOU, Emilie et al.Brain research. 2013, Vol 1511, pp 65-72, issn 0006-8993, 8 p.Article

5-HT4 receptor agonism in the five-choice serial reaction time taskHILLE, Christopher; BATE, Simon; DAVIS, John et al.Behavioural brain research. 2008, Vol 195, Num 1, pp 180-186, issn 0166-4328, 7 p.Article

A high-affinity monoclonal antibody with functional activity against the 5-hydroxytryptaminergic (5-HT₄) receptorKAMEL, Rehab; EFTEKHARI, Pierre; GARCIA, Simone et al.Biochemical pharmacology. 2005, Vol 70, Num 7, pp 1009-1018, issn 0006-2952, 10 p.Article